Astral Codex Ten Podcast cover image

Your Book Review: Lying for Money

Astral Codex Ten Podcast

00:00

The Dangers of Forging Documents

In the 1990s, British biotech was at the very earliest stages of testing an anti-cancer drug called merrimastat. The FDA's immediate response was to say that you cannot measure tumor size by counting antigen levels. Davies notes that sometimes counterfeiting stretches past its strict legal definition and doesn't necessarily require forging documents.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app